|
EORTC QLQ-C30:
| | | |
|
Functional scales:
| | | |
|
Physical function
|
34
|
0.87
|
0.76-0.93
|
|
Role function
|
33
|
0.80
|
0.64-0.90
|
|
Emotional function
|
34
|
0.73
|
0.52-0.85
|
|
Cognitive function
|
34
|
0.79
|
0.62-0.89
|
|
Social function
|
34
|
0.84
|
0.71-0.92
|
|
Global QoL/GHS
|
34
|
0.33
|
-0.01-0.59
|
|
Symptom scales:
| | | |
|
Fatigue
|
34
|
0.82
|
0.67-0.90
|
|
Pain
|
34
|
0.74
|
0.54-0.86
|
|
Nausea and vomiting
|
34
|
0.43
|
0.11-0.67
|
|
Single items
c
:
| | | |
|
Dyspnoea
|
34
|
0.63
|
0.37-0.79
|
|
Sleep disturbance
|
34
|
0.76
|
0.58-0.87
|
|
Appetite loss
|
34
|
0.74
|
0.54-0.86
|
|
Diarrhoea
|
34
|
0.33
|
-0.003-0.60
|
|
Constipation
|
34
|
0.54
|
0.25-0.74
|
|
Financial impact
|
34
|
0.75
|
0.56-0.87
|
|
EORTC QLQ-CR38:
| | | |
|
Functional scales:
| | | |
|
Body image
|
32
|
0.71
|
0.49-0.85
|
|
Future perspective
|
32
|
0.76
|
0.56-0.87
|
|
Sexual functioning
|
31
|
0.82
|
0.66-0.91
|
|
Sexual enjoyment
|
11
|
NA
|
NA
|
|
Symptom scales:
| | | |
|
Radiation-induced effects micturition
|
32
|
0.67
|
0.43-0.82
|
|
Chemotherapy side effects
|
32
|
0.70
|
0.47-0.84
|
|
General gastrointestinal symptoms
|
32
|
0.65
|
0.39-0.81
|
|
Defecation problems
|
26
|
NA
|
NA
|
|
Stoma-related problems
|
6
|
NA
|
NA
|
|
Sexual dysfunction of men
|
14
|
NA
|
NA
|
|
Sexual dysfunction of women
|
3
|
NA
|
NA
|
|
Weight loss
|
32
|
0.36
|
0.02-0.63
|
|
FACT-C:
| | | |
|
Physical Well-Being
|
34
|
0.76
|
0.57-0.87
|
|
Social/Family Well-Being
|
33
|
0.51
|
0.23-0.73
|
|
Emotional Well-Being
|
34
|
0.79
|
0.62-0.89
|
|
Functional Well-Being
|
34
|
0.73
|
0.52-0.85
|
|
Colorectal Cancer Specific
|
34
|
0.77
|
0.59-0.90
|
|
FACT-C total score
|
34
|
0.75
|
0.55-0.87
|
|
Trial Outcome Index-Colorectal
|
34
|
0.82
|
0.66-0.90
|
